{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:15:05Z","timestamp":1791112505157,"version":"4.1.0"},"reference-count":77,"publisher":"Japan Atherosclerosis Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2009]]},"DOI":"10.5551\/jat.e598","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:38Z","timestamp":1308231938000},"page":"145-154","source":"Crossref","is-referenced-by-count":127,"title":["Remnant Lipoproteins As Strong Key Particles to Atherogenesis"],"prefix":"10.5551","volume":"16","author":[{"given":"Yoshio","family":"Fujioka","sequence":"first","affiliation":[{"name":"Laboratory of Nutritional Physiology, Faculty of Nutrition, Kobegakuin University, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Kobe University Graduate School of Health Sciences, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kannel WB, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and risk of coronary heart disease: The Framingham study. Ann Intern Med, 1971; 74: 1-12","DOI":"10.7326\/0003-4819-74-1-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Iso H, Naito Y, Sato S, Kitamura A, Okamura T, Sankai T, Shimamoto T, Iida M, Komachi Y: Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol, 2001; 153: 490-499","DOI":"10.1093\/aje\/153.5.490"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Eberly LE, Stamler J, Neaton JD, for the Multiple Risk Factor Intervention Trial Research Group: Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med, 2003; 163; 1077-1083","DOI":"10.1001\/archinte.163.9.1077"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Imaizumi K, Fainaru M, Havel RJ: Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins. J Lipid Res, 1978; 19: 712-722","DOI":"10.1016\/S0022-2275(20)41271-4"},{"key":"5","unstructured":"5) Cooper AD: In: Zakim D, Boyer T. editors. Hepatology: a textbook of liver disease. 2nd edn. Vol.1. Philadelphia: WB Saunders; 1989; 96-123"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Cooper AD: Hepatic uptake of chylomicron remnants. J Lipid Res, 1997; 38: 2173-2192","DOI":"10.1016\/S0022-2275(20)34932-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Mahley RW, Huang Y: Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. J Clin Invest, 2007; 117: 94-98","DOI":"10.1172\/JCI30889"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Zilversmit DB: Atherogenesis: a postprandial phenomenon. Circulation, 1979; 60: 473-485","DOI":"10.1161\/01.CIR.60.3.473"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Scow RO, Egelrud T: Hydrolysis of chylomicron phosphatidylcholine in vitro by lipoprotein lipase, phospholipase A2 and phospholipase C. Biochim Biophys Acta, 1976; 431: 538-549","DOI":"10.1016\/0005-2760(76)90219-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Morimoto S, Fujioka Y, Hosoai H, Okumura T, Masai M, Sakoda T, Tsujino T, Ohyanagi M, Iwasaki T: The renin-angiotensin system is involved in the production of plasminogen activator inhibitor type 1 by cultured endothelial cells in response to chylomicron remnants. Hypertens Res, 2003; 26: 315-323","DOI":"10.1291\/hypres.26.315"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Liu-Wu Y, Hurt-Camejo E, Wiklund O: Lysophosphatidylcholine induces the production of IL-1beta by human monocytes. Atherosclerosis, 1998; 137: 351-357","DOI":"10.1016\/S0021-9150(97)00295-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Thomas CE, Jackson RL, Ohlweiler DF, Ku G: Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. J Lipid Res, 1994; 35: 417-427","DOI":"10.1016\/S0022-2275(20)41193-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Lambert MS, Avella MA, Berhane Y, Shervill E, Botham KM: The fatty acid composition of chylomicron remnants influences their binding and internalization by isolated hepatocytes. Eur J Biochem, 2001; 268: 3983-3992","DOI":"10.1046\/j.1432-1327.2001.02311.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Staprans I, Rapp JH, Pan XM, Feingold KR: Oxidized lipids in the diet are incorporated by the liver into very low density lipoprotein in rats. J Lipid Res, 1996; 37: 420-430","DOI":"10.1016\/S0022-2275(20)37628-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Zheng C, Murdoch SJ, Brunzell JD, Sacks FM: Lipoprotein lipase bound to apolipoprotein B lipoproteins accelerates clearance of postprandial lipoproteins in humans. Arterioscler Thromb Vasc Biol, 2006; 26: 891-896","DOI":"10.1161\/01.ATV.0000203512.01007.3d"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ: Cholesterol in remnant-like particles in human serum using monoclonal anti apo B-100 and anti A-I immunoaffinity mixed gel. Clin Chim Acta, 1993; 223: 53-71","DOI":"10.1016\/0009-8981(93)90062-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Campos E, Nakajima K, Tanaka A, Havel RJ: Properties of an apolipoprotein E-enriched fraction of triglyceride- rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res, 1992; 33: 369-380","DOI":"10.1016\/S0022-2275(20)41527-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Marcoux C, Tremblay M, Nakajima K, Davignon J, Cohn JS: Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients. J Lipid Res, 1999; 40: 636-647","DOI":"10.1016\/S0022-2275(20)32142-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Campos E, Kotite L, Blanche P, Mitsugi Y, Frost PH, Masharani U, Krauss RM, Havel RJ: Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma. J Lipid Res, 2002; 43: 365-374","DOI":"10.1016\/S0022-2275(20)30142-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Miyauchi K, Kayahara N, Ishigami M, Kuwata H, Mori H, Sugiuchi H, Irie T, Tanaka A, Yamashita S, Yamamura T: Development of a homogeneous assay to measure remnant lipoprotein cholesterol. Clin Chem, 2007; 53: 2128-2135","DOI":"10.1373\/clinchem.2007.092296"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Nakada Y, Kurosawa H, Tohyama J, Inoue Y, Ikewaki K: Increased remnant lipoprotein in patients with coronary artery disease-evaluation utilizing a newly developed remnant assay, remnant lipoproteins cholesterol homogenous assay (RemL-C). J Atheroscler Thromb, 2007; 14: 56-64","DOI":"10.5551\/jat.14.56"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sato I, Ishikawa Y, Ishimoto A, Katsura S, Toyokawa A, Hayashi F, Kawano S, Fujioka Y, Yamashita S, Kumagai S: Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period. J Atheroscler Thromb, in press","DOI":"10.5551\/jat.E596"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Yu KC, Cooper AD: Postprandial lipoproteins and atherosclerosis. Front Biosci, 2001; 6: D332-D354","DOI":"10.2741\/Yu"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Tanaka A: Postprandial hyperlipidemia and atherosclerosis. J Atheroscler Thromb, 2004; 11: 322-329","DOI":"10.5551\/jat.11.322"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Devaraj S, Vega G, Lange R, Grundy SM, Jialal I: Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease. Am J Med, 1998; 104: 445-450","DOI":"10.1016\/S0002-9343(98)00089-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H: Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation, 1999; 99: 2858-2860","DOI":"10.1161\/01.CIR.99.22.2858"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Karpe F, Boquist S, Tang R, Bond GM, de Faire U, Hamsten A: Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J Lipid Res, 2001; 42: 17-21","DOI":"10.1016\/S0022-2275(20)32331-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Imke C, Rodriguez BL, Grove JS, McNamara JR, Waslien C, Katz AR, Willcox B, Yano K, Curb JD: Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study. Arterioscler Thromb Vasc Biol, 2005; 25: 1718-1722","DOI":"10.1161\/01.ATV.0000173310.85845.7b"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Watanabe N, Taniguchi T, Taketoh H, Kitagawa Y, Namura H, Yoneda N, Kurimoto Y, Yamada S, Ishikawa Y: Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care, 1999; 22: 152-156","DOI":"10.2337\/diacare.22.1.152"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Cohn JS, Marcoux C, Davignon J: Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins. Arterioscler Thromb Vasc Biol, 1999; 19: 2474-2486","DOI":"10.1161\/01.ATV.19.10.2474"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Karpe F: Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med, 1999; 246: 341-355","DOI":"10.1046\/j.1365-2796.1999.00548.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Karpe F, Hell&eacute;nius ML, Hamsten A: Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease. Metabolism, 1999; 48: 301-307","DOI":"10.1016\/S0026-0495(99)90076-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Uchida Y, Kurano Y, Ito S: Establishment of monoclonal antibody against human ApoB-48 and measurement of ApoB-48 in serum by ELISA method. J Clin Lab Anal, 1998; 12: 289-292","DOI":"10.1002\/(SICI)1098-2825(1998)12:5<289::AID-JCLA7>3.0.CO;2-1"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Sakai N, Uchida Y, Ohashi K, Hibuse T, Saika Y, Tomari Y, Kihara S, Hiraoka H, Nakamura T, Ito S, Yamashita S, Matsuzawa Y: Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. J Lipid Res, 2003; 44: 1256-1262","DOI":"10.1194\/jlr.M300090-JLR200"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kinoshita M, Kojima M, Matsushima T, Teramoto T: Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta, 2005; 351: 115-120","DOI":"10.1016\/j.cccn.2004.08.008"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Fainaru M, Mahley RW, Hamilton RL, Innerarity TL: Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with Type III hyperlipoproteinemia. J Lipid Res, 1982; 23: 702-714","DOI":"10.1016\/S0022-2275(20)38102-5"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Daugherty A, Lange LG, Sobel BE, Schonfeld G: Aortic accumulation and plasma clearance of &beta;-VLDL and HDL: effects of diet-induced hypercholesterolemia in rabbits. J Lipid Res, 1985; 26: 955-963","DOI":"10.1016\/S0022-2275(20)34298-X"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, Kotite L, Kunitake ST, Havel RJ, Kane JP: Triglyceride-rich lipoproteins isolated by selective-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb, 1994; 14: 1767-1774","DOI":"10.1161\/01.ATV.14.11.1767"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Proctor SD, Mamo JC: Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol, 2003; 23: 1595-1600","DOI":"10.1161\/01.ATV.0000084638.14534.0A"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Mohrschladt MF, Weverling-Rijnsburger AW, de Man FH, Stoeken DJ, Sturk A, Smelt AH, Westendorp RG: Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy. Atherosclerosis, 2000; 148: 413-419","DOI":"10.1016\/S0021-9150(99)00316-0"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Van Oostrom AJ, Rabelink TJ, Verseyden C, Sijmonsma TP, Plokker HW, De Jaegere PP, Cabezas MC: Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis, 2004; 177: 175-182","DOI":"10.1016\/j.atherosclerosis.2004.07.004"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Alipour A, van Oostrom AJ, Izraeljan A, Verseyden C, Collins JM, Frayn KN, Plokker TW, Elte JW, Cabezas MC: Leukocyte activation by triglyceride-rich lipoproteins. Arterioscler Thromb Vasc Biol, 2008; 28: 792-797","DOI":"10.1161\/ATVBAHA.107.159749"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Reape TJ, Groot PH: Chemokines and atherosclerosis. Atherosclerosis, 1999; 147: 213-225","DOI":"10.1016\/S0021-9150(99)00346-9"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Maeno Y, Kashiwagi A, Nishio Y, Takahara N, Kikkawa R: IDL can stimulate atherogenic gene expression in cultured human vascular endothelial cells. Diabetes Res Clin Prac, 2000; 48: 127-138","DOI":"10.1016\/S0168-8227(99)00147-3"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Park SY, Lee JH, Kim YK, Kim CD, Rhim BY, Lee WS, Hong KW: Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation. J Pharmacol Exp Ther, 2005; 312: 1241-1248","DOI":"10.1124\/jpet.104.077826"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Domoto K, Taniguchi T, Takaishi H, Takahashi T, Fujioka Y, Takahashi A, Ishikawa Y, Yokoyama M: Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells. Atherosclerosis, 2003; 171: 193-200","DOI":"10.1016\/j.atherosclerosis.2003.08.016"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Takahashi Y, Fujioka Y, Takahashi T, Domoto K, Takahashi A, Taniguchi T, Ishikawa Y, Yokoyama M: Chylomicron remnants regulate early growth response factor-1 in vascular smooth muscle cells. Life Sci, 2005; 77: 670-682","DOI":"10.1016\/j.lfs.2005.01.012"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Silverman ES, Collins T: Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol, 1999; 154: 665-670","DOI":"10.1016\/S0002-9440(10)65312-6"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Doi H, Kugiyama K, Oka H, Sugiyama S, Ogata N, Koide SI, Nakamura SI, Yasue H: Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation, 2000; 102: 670-676","DOI":"10.1161\/01.CIR.102.6.670"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Kawakami A, Tanaka A, Nakajima K, Shimokado K, Yoshida M: Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res, 2002; 91: 263-271","DOI":"10.1161\/01.RES.0000028454.42385.8B"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Eriksson P, Nilsson L, Karpe F, Hamsten A: Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler Thromb Vasc Biol, 1998; 18: 20-26","DOI":"10.1161\/01.ATV.18.1.20"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Kawasaki S, Taniguchi T, Fujioka Y, Takahashi A, Takahashi T, Domoto K, Taguchi M, Ishikawa Y, Yokoyama M: Chylomicron remnant induces apoptosis in vascular endothelial cells. Ann N Y Acad Sci, 2000; 902: 336-341","DOI":"10.1111\/j.1749-6632.2000.tb06334.x"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Shin HK, Kim YK, Kim KY, Lee JH, Hong KW: Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation, 2004; 109: 1022-1028","DOI":"10.1161\/01.CIR.0000117403.64398.53"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Chowienczyk PJ, Watts GF, Wierzbicki AS, Cockcroft JR, Brett SE, Ritter JM: Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. J Am Coll Cardiol, 1997; 29: 964-968","DOI":"10.1016\/S0735-1097(97)00033-8"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Lundman P, Eriksson M, Schenck-Gustafsson K, Karpe F, Tornvall P: Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation, 1997; 96: 3266-3268","DOI":"10.1161\/01.CIR.96.10.3266"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Goulinet S, Chapman MJ: Plasma LDL and HDL subspecies are heterogeneous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids: relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol, 1997; 17: 786-796","DOI":"10.1161\/01.ATV.17.4.786"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H, Nakagawa O, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, Nakano T, Nakajima K, Yasue H: Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation, 1998; 97: 2519-2526","DOI":"10.1161\/01.CIR.97.25.2519"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Okumura T, Fujioka Y, Morimoto S, Tsuboi S, Masai M, Tsujino T, Ohyanagi M, Iwasaki T: Eicosapentaenoic acid improves endothelial function in hypertriglyceridemic subjects despite increased lipid oxidizability. Am J Med Sci, 2002; 324: 247-253","DOI":"10.1097\/00000441-200211000-00003"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: modification of low-density lipoprotein that increases its atherogenicity. New Engl J Med, 1989; 320: 915-924","DOI":"10.1056\/NEJM198904063201407"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Pitas RE, Innerarity TL, Mahley RW: Foam cells in explants of atherosclerotic rabbit aortas have receptors for beta-very low density lipoproteins and modified low density lipoproteins. Arteriosclerosis, 1983; 3: 2-12","DOI":"10.1161\/01.ATV.3.1.2"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Fujioka Y, Cooper AD, Fong LG: Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages. J Lipid Res, 1998; 39: 2339-2349","DOI":"10.1016\/S0022-2275(20)33313-7"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Brown ML, Ramprasad MP, Umeda PK, Tanaka A, Kobayashi Y, Watanabe T, Shimoyamada H, Kuo WL, Li R, Song R, Bradley WA, Gianturco SH: A macrophage receptor for apolipoprotein B48: cloning, expression, and atherosclerosis. Proc Natl Acad USA, 2000; 97: 7488-7493","DOI":"10.1073\/pnas.120184097"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Kawakami A, Tani M, Chiba T, Yui K, Shinozaki S, Nakajima K, Tanaka A, Shimokado K, Yoshida M: Pitavastatin inhibits remnant lipoprotein-induced macrophage foam cell formation through ApoB48 receptor-dependent mechanism. Arterioscler Thromb Vasc Biol, 2005; 25: 424-429","DOI":"10.1161\/01.ATV.0000152632.48937.2d"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Aramaki Y, Mitsuoka H, Toyohara M, Jinnai T, Kanatani K, Nakajima K, Mukai E, Yamada Y, Kita T, Inagaki N, Kume N: Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells. Atherosclerosis, 2008; 198: 272-279","DOI":"10.1016\/j.atherosclerosis.2007.12.017"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Ellsworth JL, Fong LG, Kraemer FB, Cooper AD: Differences in the processing of chylomicron remnants and &beta;- VLDL by macrophages. J Lipid Res, 1990; 31: 1399-1411","DOI":"10.1016\/S0022-2275(20)42611-2"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Tabas I, Lim S, Xu XX, Maxfield FR: Endocytosed &beta;- VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages. J Cell Biol, 1990; 111: 929-940","DOI":"10.1083\/jcb.111.3.929"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Tabas I, Myers JN, Innerarity TL, Xu XX, Arnold K, Boyles J, Maxfield FR: The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of &beta;-VLDL in mouse peritoneal macrophages. J Cell Biol, 1991; 115: 1547-1560","DOI":"10.1083\/jcb.115.6.1547"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Libby P: Inflammation in atherosclerosis. Nature, 2002; 420: 868-874","DOI":"10.1038\/nature01323"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Okumura T, Fujioka Y, Morimoto S, Masai M, Sakoda T, Tsujino T, Kashiwamura S, Okamura H, Ohyanagi M: Chylomicron remnants stimulate release of interleukin-1&beta; by THP-1 cells. J Atheroscler Thromb, 2006; 13: 38-45","DOI":"10.5551\/jat.13.38"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Sch&ouml;nbeck U, Libby P: CD40 signaling and plaque instability. Circ Res, 2001; 89: 1092-1103","DOI":"10.1161\/hh2401.101272"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Kamemura K, Fujioka Y, Takaishi H, Takahashi A, Taniguchi T, Ishikawa Y, Yokoyama M: Chylomicron remnants upregulate CD40 expression via the ERK pathway and a redox-sensitive mechanism in THP-1 cells. Atherosclerosis, 2006; 187: 257-264","DOI":"10.1016\/j.atherosclerosis.2005.09.002"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Flor&eacute;n CH, Albers JJ, Bierman EL: Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells. Biochim Biophys Acta, 1981; 663: 336-349","DOI":"10.1016\/0005-2760(81)90219-8"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Zhao D, Letterman J, Schreiber BM: &beta;-migrating very low density lipoprotein (&beta;VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor: effect of MAP kinase activation on &beta;VLDL plus EGF-induced cell proliferation. J Biol Chem, 2001; 276: 30579-30588","DOI":"10.1074\/jbc.M103761200"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Kawakami A, Tanaka A, Nakano T, Saniabadi A, Numano F: Stimulation of arterial smooth muscle cell proliferation by remnant lipoprotein particles isolated by immuno-affinity chromatography with anti-apo A-I and anti-apoB-100. Horm Metab Res, 2001; 33: 67-72","DOI":"10.1055\/s-2001-12397"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Kawakami A, Tanaka A, Chiba T, Nakajima K, Shimokado K, Yoshida M: Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation, 2003; 108: 2679-2688","DOI":"10.1161\/01.CIR.0000093278.75565.87"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Yoshino G, Hirano T, Kazumi T: Treatment of small dense LDL. J Atheroscler Thromb, 2002; 9: 266-275","DOI":"10.5551\/jat.9.266"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Hulthe J, Bokemark L, Wikstrand J, Fagerberg B: The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol, 2000; 20: 2140-2147","DOI":"10.1161\/01.ATV.20.9.2140"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/16\/3\/16_E598\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T09:56:58Z","timestamp":1637834218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/16\/3\/16_E598\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.e598","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}